Ibrance
- Product NDC
- 63539-187
- 11-digit product format
- 635390187
- Labeler code
- 63539
- Product ID
- 63539-187_fa0d4a01-f6f9-4e10-ad58-fdfd23a8ead2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- palbociclib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- U.S. Pharmaceuticals
- Application
- NDA207103
- Marketing category
- NDA
- Marketing start
- 2017-05-08
- Substance
- PALBOCICLIB
- Active strength
- 75 mg/1
- Pharmacologic classes
- Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63539-187-11 | Ibrance | 21 in 1 BOTTLE | CAPSULE | 21 | | 11 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63539-187 | IBRANCE (PALBOCICLIB) CAPSULE [U.S. PHARMACEUTICALS] | 9 | Current NDC, Legacy NDC, 1 package rows | 20250426_86718885-da44-4d3d-b3ca-06cbcedcffd8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63539-187-11 | 63539018711 | 21 CAPSULE in 1 BOTTLE (63539-187-11) | 21 capsule | 2017-05-08 | 0000-00-00 | No | No | Current |